{"status": "Ok", "redirect_url": "https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Open-Label-Outpatient-Switch-Study-Demonstrates-Symptom-Stability-During-Transition-from-Oral-Atypical-Antipsychotics-to-Cobenfy-xanomeline-and-trospium-chloride/default.aspx", "message": "News view counter 632038 successfully enlarged"}